Navigation Links
Research Shows Non-Chain Restaurants Serve Excessive Calorie Meals, Making Appetite Suppressants Like Liproxenol Helpful With Maintaining Portion Control
Date:5/30/2013

Sydney, Australia (PRWEB) May 30, 2013

Some people choose restaurants based on the size of portions they serve. However, researchers have found that the majority of non-chain restaurants may be serving up almost enough to cover a person’s daily caloric requirement in that one meal, making appetite suppressants like Liproxenol beneficial for portion control when the establishment serves too much food.

In a study published May 13, 2013 by JAMA Internal Medicine, it states that more than 50% of the restaurants across the U.S. do not list the calorie information about their food. These are primarily non-chain or independent eateries as most chain restaurants do display their nutritional information on their menu.

The researchers looked at 157 different meals from these types of eateries. They were comprised of 42 of the most popular meals across 9 regular menu categories. And, they were all available from independent food businesses within a 15 mile radius of the downtown Boston, Massachusetts area.

What they found is that the average meal contained 1327 calories, which is two-thirds of a person’s daily caloric requirement. Of those, 7.6% had high enough calorie counts to cover 100% of a person’s recommended intake. Also, their average meal calories were 49% higher than in some of the larger chain establishments.

This study suggests that eating at places that don’t display the calorie content of their food will likely result in more calories being presented in the meal. Therefore, appetite control supplements such as Liproxenol may assist individuals with maintaining proper portion control when the restaurant establishments put excessive amounts of food on the plate they place in front of their patrons.

Liproxenol is a weight loss supplement that contains all natural ingredients such as green tea, vitamin B6, cayenne powder and dandelion root. It was created by Liproxenol Nutraceuticals to increase metabolism, decrease appetite and burn excess fat.

About Liproxenol Nutraceuticals:

Liproxenol Nutraceuticals is recognized as an industry leader in the fields of health, wellness and better living. The company's products are enjoyed by customers around the world and are among a new class of supplements that are not only effective but also safe and made from 100% all-natural ingredients. Liproxenol Nutraceuticals is based in Australia and the USA.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10495833.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Hospitals in the UK Industry Market Research Report Now Updated by IBISWorld
2. 5 CU-Boulder Students Patent New Medical Device Through Partnership With CU Cancer Center researcher
3. Researchers shed new light on egg freezing success rates
4. Father and son to present their respective cancer research at ASCO
5. Study finds that radiation oncology research is critically underfunded by NIH
6. Junk DNA plays active role in cancer progression, researchers find
7. American Cancer Society honors Isaiah J. Fidler for outstanding research
8. Research by the Montana Center for Work Physiology and Exercise Metabolism Proves Heat Stroke Death Can Occur Even When Properly Hydrated
9. Biochip Products and Services Market - New Market Research Report Published by Transparency Market Research
10. Water & Wastewater Treatment Equipment Market- Disinfection, Filtration, Distillation & Testing Analysis in New Research Report at ReportsnReports.com
11. HealthEconomics.Com Distinguished As Top Influencer at the International Society for Pharmacoeconomics and Outcomes Research 18th Annual International Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016 Research and Markets has ... Companion Diagnostic Tests" report to their offering. ... Diagnostics The World Market for Companion Diagnostics ... diagnostics. Market analysis in the report includes the following: ... Vitro Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology: